Does Rallies show Form 4 insider transactions for CNO?

Yes. Rallies tracks CNO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CNO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CNO. It does not provide personalized investment advice.

CNO (CNO Financial Group, Inc.) Stock Analysis - Insider Trades

CNO Financial Group, Inc. (CNO) is a publicly traded Financial Services sector company. As of May 21, 2026, CNO trades at $47.38 with a market cap of $4.47B and a P/E ratio of 12.38. CNO moved +0.77% today. Year to date, CNO is +9.63%; over the trailing twelve months it is +20.39%. Its 52-week range spans $33.85 to $47.95. Analyst consensus is sell with an average price target of $46.50. Rallies surfaces CNO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CNO stock inside the company?

Recent CNO insider activity includes Goldberg Scott L. sold 11.06K, Goldberg Scott L. sold 11.06K, Zimpfer Matthew J. sold 33.80K, Bhojwani Gary C. sold 43.02K, and Zimpfer Matthew J. sold 23.57K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CNO Key Metrics

Key financial metrics for CNO
Metric	Value
Price	$47.38
Market Cap	$4.47B
P/E Ratio	12.38
EPS	$3.81
Dividend Yield	0.18%
52-Week High	$47.95
52-Week Low	$33.85
Volume	12
Avg Volume	0
Revenue (TTM)	$4.45B
Net Income	$404.00M
Gross Margin	0.00%

Recent CNO Insider Trades

Goldberg Scott L. sold 11.06K (~$437.35K) on Mar 20, 2026.
Goldberg Scott L. sold 11.06K (~$442.08K) on Mar 19, 2026.
Zimpfer Matthew J. sold 33.80K (~$1.46M) on Feb 18, 2026.
Bhojwani Gary C. sold 43.02K (~$1.85M) on Feb 18, 2026.
Zimpfer Matthew J. sold 23.57K (~$1.02M) on Feb 17, 2026.

Latest CNO News

CNO Financial Q1 Operating Income Soars 33% to $101M, Medicare Sales Up 24% — Apr 30, 2026
Middle-Class Retirement Confidence Drops to 32% as Inflation, Social Security Cuts Raise Concerns — Mar 5, 2026
Bankers Life Launches Enhanced Death Benefit Rider for GLIA and GLIA Plus Annuities Up to $2 Million — Mar 4, 2026
32% of Middle-Income Americans Lose Retirement Confidence, 47% Fear Medicare Cuts — Feb 18, 2026
Q4 Revenue Hits $1.01B, Adjusted EPS Jumps 21.9% on Medicare Supplement Surge — Feb 6, 2026

CNO Analyst Consensus

2 analysts cover CNO: 0 strong buy, 0 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $46.50.

Common questions about CNO

Who is trading CNO stock inside the company?: Recent CNO insider activity includes Goldberg Scott L. sold 11.06K, Goldberg Scott L. sold 11.06K, Zimpfer Matthew J. sold 33.80K, Bhojwani Gary C. sold 43.02K, and Zimpfer Matthew J. sold 23.57K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CNO?: Yes. Rallies tracks CNO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CNO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CNO. It does not provide personalized investment advice.